Revolution in oncology: Professor Chow expands cancer therapy in Offenbach

Revolution in oncology: Professor Chow expands cancer therapy in Offenbach

With a clear goal in mind, Professor Dr. Kai Uwe Chow is significantly developing cancer therapy at the Sana Clinic Offenbach. Since April 2025, he has taken over the management of the Hematology and Oncology Department and plans to optimize patient care through numerous initiatives. In Germany, around 500,000 people receive the shocking diagnosis of cancer every year, which shows how important Chow's commitment is. Loud op online The probability of developing cancer in the course of a lifetime is 43% for women and 51% for men. Cancer is the second most common cause of death in Germany, accounting for around 20% of all deaths.

Chow comes to the Sana Clinic not only with impressive expertise, but also with personal roots in the Offenbach region, where his parents worked. He previously co-founded the South Outpatient Cancer Center in Frankfurt and is now leading the effort to further expand the certified Oncological Center Offenbach (OCO). The clinic is also planning a hematology center to treat blood diseases, which could significantly improve care options for cancer patients.

A strong team for oncology

Professor Chow's team currently consists of three senior physicians and three assistant physicians, and the plans are big: it will be expanded to include at least three additional positions. “Interdisciplinary collaboration is crucial,” he emphasizes, “particularly in the development of individualized treatment plans.” This approach is complemented by recent advances in diagnostics, such as gene sequencing, which enable tailored therapy. And as cancer therapies increasingly change from chemotherapy and radiation therapy to targeted therapies and immunotherapies, the Sana Clinic is becoming a potential driving force in the Rhine-Main area.

One of the focuses of Chow's work is expanding the study center at OCO. By engaging in clinical trials, cancer patients have the opportunity to gain early access to new, innovative treatment methods. These studies are crucial not only for personal patient care, but also for improving medical standards overall. As on the website of the Cancer Society As explained, clinical studies offer a valuable opportunity - but also risks that patients should weigh carefully.

The importance of research and data

Much has been achieved in hematology, a focus of Chow's work, in recent years. The survival rate for blood and lymph node cancer is now between 45% and 65% five years after diagnosis. These positive developments are largely due to intensive research efforts, which also include the collection and analysis of cancer data. The Center for Cancer Registry Data at the Robert Koch Institute, about which krebsgesellschaft.de being informed plays a central role here. It enables the evaluation of epidemiological data and thus contributes to improving care.

One thing is certain: the work of Professor Dr. Kai Uwe Chow at the Sana Clinic will have a long-term positive impact on cancer therapy in the region. With a strong team and a focus on clinical research and interdisciplinary collaboration, the foundation has been laid not only to improve local care, but also to make a significant contribution to oncology in the Rhine-Main area.